🟠 Alyftrek offers a safe, once-daily alternative for pediatric CF patients with significant #CFTR improvements; long-term extension studies will further confirm its clinical benefits. 
#CRISPR #biotech $VRTX $NTLA $PRME $EDIT @FDA